Scientific Manuscripts
- Brachman DG, Wang M, Ashby LS, Thomas TA, Dunbar EM, Rockhill JK, Khuntia D, Bovi JA, Macher MS, Mehta MP. Phase II trial of temozolomide (TMZ) , motexafin gadolinium (MGd), and 60 Gy fractionated radiation (RT) for newly diagnosed supratentorial glioblastoma (GBM): Results of RTOG 0513 [Oral presentation]. 2011 American Society of Therapeutic Radiology and Oncology Annual Meeting, Miami Beach, FL, October 2-6, 2011.
- Evens A, Spies W, Helenowski I, et al. The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin’s Lymphoma: Preclinical Findings and Results of a Phase I Trial. Clin Cancer Res. Oct 2009; 15(20):6462-6471.
